BLCV vs. BMED

Last updated Jun 24, 2026

BLCV (Blackrock Large Cap Value ETF) and BMED (Future Health ETF) are both exchange-traded funds - BLCV is a Large Cap Value Equities fund actively managed by BlackRock, while BMED is a Health & Biotech Equities fund actively managed by BlackRock. Both are actively managed. Over the past 3 years, BLCV returned 18.17%/yr vs 5.62%/yr for BMED. A 0.63 correlation means they provide meaningful diversification when combined. BLCV charges 0.55%/yr vs 0.85%/yr for BMED.

Performance

BLCV vs. BMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Blackrock Large Cap Value ETF (BLCV) and Future Health ETF (BMED). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BLCV achieves a 6.47% return, which is significantly higher than BMED's -4.52% return.

BLCV

• 1D: -1.81%
• 1M: 0.18%
• YTD: 6.47%
• 6M: 5.91%
• 1Y: 18.72%
• 3Y*: 18.17%
• 5Y*: —
• 10Y*: —

BMED

• 1D: 1.07%
• 1M: 3.10%
• YTD: -4.52%
• 6M: -5.65%
• 1Y: 19.02%
• 3Y*: 5.62%
• 5Y*: -0.97%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BLCV vs. BMED - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
BLCV Blackrock Large Cap Value ETF	6.47%	19.96%	12.63%	14.56%
BMED Future Health ETF	-4.52%	21.79%	1.55%	-0.11%

Correlation

The correlation between BLCV and BMED is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.59
Correlation (3Y) Calculated over the trailing 3-year period	0.62
Correlation (All Time) Calculated using the full available price history since May 23, 2023	0.63

The correlation between BLCV and BMED has been stable across timeframes, ranging from 0.59 to 0.63 - a consistent structural relationship.

BLCV vs. BMED - Sectors Allocation Comparison

Sectors	BLCV	BMED
Technology	18.3%	-
Financial Services	14.9%	-
Industrials	14.2%	-
Healthcare	11.6%	100.0%
Consumer Cyclical	9.9%	-
Communication Services	9.5%	-
Consumer Defensive	6.1%	1.5%
Energy	6.0%	-
Utilities	4.4%	-
Real Estate	2.7%	-
Basic Materials	2.4%	-

Return for Risk

BLCV vs. BMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLCV

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

BMED

BMED Risk / Return Rank: 32
BMED Sharpe Ratio Rank: 37
BMED Sortino Ratio Rank: 38
BMED Omega Ratio Rank: 34
BMED Calmar Ratio Rank: 28
BMED Martin Ratio Rank: 25

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLCV vs. BMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Blackrock Large Cap Value ETF (BLCV) and Future Health ETF (BMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BLCV	BMED	Difference
Sharpe ratio: Return per unit of total volatility	1.79	1.24	+0.55
Sortino ratio: Return per unit of downside risk	2.59	1.84	+0.75
Omega ratio: Gain probability vs. loss probability	1.32	1.22	+0.10
Calmar ratio: Return relative to maximum drawdown	2.11	1.29	+0.82
Martin ratio: Return relative to average drawdown	8.49	3.01	+5.48

BLCV vs. BMED - Sharpe Ratio Comparison

The current BLCV Sharpe Ratio is 1.79, which is higher than the BMED Sharpe Ratio of 1.24. The chart below compares the historical Sharpe Ratios of BLCV and BMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BLCV vs. BMED - Drawdown Comparison

The maximum BLCV drawdown since its inception was -13.44%, smaller than the maximum BMED drawdown of -36.44%. Use the drawdown chart below to compare losses from any high point for BLCV and BMED.

Drawdown Indicators

	BLCV	BMED	Difference
Max Drawdown Largest peak-to-trough decline	-13.44%	-36.44%	+23.00%
Max Drawdown (1Y) Largest decline over 1 year	-9.92%	-14.85%	+4.93%
Max Drawdown (3Y) Largest decline over 3 years	-13.44%	-20.12%	+6.68%
Max Drawdown (5Y) Largest decline over 5 years	—	-33.90%	—
Current Drawdown Current decline from peak	-1.81%	-10.54%	+8.73%
Average Drawdown Average peak-to-trough decline	-2.05%	-19.01%	+16.96%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.46%	6.34%	-3.88%

Volatility

BLCV vs. BMED - Volatility Comparison

The current volatility for Blackrock Large Cap Value ETF (BLCV) is 3.36%, while Future Health ETF (BMED) has a volatility of 4.76%. This indicates that BLCV experiences smaller price fluctuations and is considered to be less risky than BMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BLCV	BMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.36%	4.76%	-1.40%
Volatility (6M) Calculated over the trailing 6-month period	9.03%	11.41%	-2.38%
Volatility (1Y) Calculated over the trailing 1-year period	11.65%	15.41%	-3.76%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	12.81%	17.45%	-4.64%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	12.81%	17.74%	-4.93%

BLCV vs. BMED - Expense Ratio Comparison

BLCV has a 0.55% expense ratio, which is lower than BMED's 0.85% expense ratio.

Dividends

BLCV vs. BMED - Dividend Comparison

BLCV has not paid dividends to shareholders, while BMED's dividend yield for the trailing twelve months is around 0.28%.

Position	TTM	2025	2024	2023
BLCV Blackrock Large Cap Value ETF	1.01%	1.37%	1.63%	1.02%
BMED Future Health ETF	0.28%	0.00%	0.00%	0.03%

Frequently Asked Questions

Can I hold both BLCV and BMED in my portfolio?

BLCV and BMED have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BLCV or BMED?

BMED has higher volatility (4.76%) compared to BLCV (3.36%). In terms of maximum drawdown, BLCV dropped -13.44% vs BMED's -36.44%.

Which ETF is better, BLCV or BMED?

On 3-year performance, BLCV leads with 18.17% vs 5.62% for BMED. On fees, BLCV is cheaper at 0.55% per year. On volatility, BLCV has been the lower-risk option at 3.36%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BLCV or BMED?

Over the 3-year period, BLCV has performed better with a 18.17% return vs 5.62%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BLCV or BMED?

BLCV is cheaper with a 0.55% expense ratio, compared with 0.85% for BMED.

Which ETF pays a higher dividend yield, BLCV or BMED?

BLCV has the higher dividend yield at 1.01%, compared with 0.28% for BMED.

What is the main difference between BLCV and BMED?

BLCV is categorized as Large Cap Value Equities, while BMED is Health & Biotech Equities. Their fees differ too: 0.55% for BLCV and 0.85% for BMED.

Which has better risk-adjusted returns?

BLCV currently has the higher Sharpe Ratio (1.79 vs 1.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.